Eliem Therapeutics to Host Digital Investor Occasion on July 21, 2022 | Nation/World
SEATTLE and CAMBRIDGE, United Kingdom, July 07, 2022 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage biotechnology firm centered on growing novel therapies for neuronal excitability problems to deal with unmet wants in power ache, psychiatry, epilepsy and different problems of the peripheral and central nervous techniques, right now introduced it would host a digital investor occasion on Thursday, July 21, 2022 beginning at 10:30 a.m. ET.
Eliem’s digital investor occasion will embody displays from Bob Azelby, president and chief government officer and Valerie Morisset, Ph.D., government vp, R&D and chief scientific officer in addition to a presentation from opinion chief John D. Markman, M.D., Vice Chair for Medical Analysis; Director, Translational Ache Analysis Program, College of Rochester. The occasion will present an in-depth evaluation of the lumbosacral radicular ache (LSRP) therapy panorama, the unmet scientific want on this indication, and ETX-810’s scientific program and potential business alternative.
Register for the occasion right here: Wall Road Webcasting – Eliem Therapeutics, Inc (wsw.com)
A dwell webcast of the occasion, in addition to a replay, might be out there underneath “Occasions and Displays” within the Traders part of the Firm’s web site: Occasions and Displays | Eliem Therapeutics, Inc. (eliemtx.com)
About Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. is a clinical-stage biotechnology firm centered on growing novel therapies for neuronal excitability problems to deal with unmet wants in power ache, psychiatry, epilepsy and different problems of the peripheral and central nervous techniques. These problems usually happen when neurons are overly excited or inhibited, resulting in an imbalance, and our focus is on restoring homeostasis. We’re growing a pipeline of clinically differentiated product candidates centered on validated mechanisms of motion with broad therapeutic potential to ship improved therapeutics for sufferers with these problems. Eliem channels its expertise, power, and fervour for enhancing sufferers’ high quality of life to gas our efforts to develop life-changing novel therapies. At its core, the Eliem crew is motivated by the promise of serving to sufferers dwell happier, extra fulfilling lives. https://eliemtx.com/
Copyright 2022 GlobeNewswire, Inc.